Philippe Leissner

2.1k citations
29 papers · 1.4k indexed · h-index 18

Impact in

Papers in

    • HIV Research and Treatment 4
    • Virus-based gene therapy research 10

Philippe Leissner

29 papers receiving 1.3k citations

Peers

Philippe Leissner
Comparison fields: 5 of 92
  • Virology 158
  • Infectious Diseases 257
  • Immunology 281
  • Oncology 290
  • Cancer Research 159
Replace Qiana L. Matthews with:
Qiana L. Matthews United States
Rebecca C. Furze United Kingdom
Dana Stein United States
M Kuppuswamy United States
Haisheng Yu China
Jerome E. Tanner Canada
Wendy G. Tan United States
Marie Frenzke United States
Shari M. Kaiser United States
Felicita Hornung United States
Philippe Leissner relative to Qiana L. Matthews United States Qiana L. Matthews's profile →
Citations per field
00.5×1.5×2.2×
Qiana L. Matthews · 1×
Citations per year

Countries citing papers authored by Philippe Leissner

Since Specialization
Citations

This map shows the geographic impact of Philippe Leissner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Leissner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Leissner more than expected).

Fields of papers citing papers by Philippe Leissner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Leissner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Leissner. The network helps show where Philippe Leissner may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Leissner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Leissner Line = papers co-authored together Philippe Leissner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202322
2 202312
3 202147
4 202114
5 202124
6 201916
7 2018133
8 201679
9
Performance of Biomarkers for Diagnosis of Hepatocellular Carcinoma–alpha Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin and Dickkopf-1
20142
10 200711
11 200621
12 200510
13 200438
14 200477
15 2004202
16 200220
17 200018
18 2000172
19
In vitro and in vivo inhibition of HIV-1 replication by retroviral transfer of TAT-inducible interferon alpha, bêta or gamma genes: application to gene therapy for Aids
19982
20 199717

About Philippe Leissner

Philippe Leissner is a scholar working on Virology, Genetics, Molecular Biology, Cancer Research and Hepatology, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), HIV Research and Treatment (4 papers), Molecular Biology Techniques and Applications (4 papers), CRISPR and Genetic Engineering (4 papers), S100 Proteins and Annexins (3 papers), Mycobacterium research and diagnosis (3 papers), RNA and protein synthesis mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Virology (158 citations), Infectious Diseases (257 citations), Immunology (281 citations), Oncology (290 citations) and Cancer Research (159 citations). Philippe Leissner has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Majid Mehtali, Alain Puisieux, Alexander Krause, Philippe Mangeot, Valérie Combaret, Sandrine Valsesia‐Wittmann, François–Loïc Cosset, Didier Négre, Thibault Verjat and Maud Magdeleine. Their work appears in journals such as Journal of Virology, BioTechniques, AIDS, Gene Therapy and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026